Effects of intra-articular administration of hyaluronic acid or platelet-rich plasma as a complementary treatment to arthroscopy in horses with osteochondritis dissecans.

Although arthroscopy is the treatment of choice for horses with osteochondritis dissecans (OCD), it is not yet known whether intra-articular therapies in the postoperative period can bring any benefit to the recovery of these animals. This study evaluated the effects of the intra-articular application of platelet-rich plasma (PRP), hyaluronic acid (HA) or lactated Ringer's solution (LR) in horses with OCD undergoing arthroscopy. Eighteen male and female Brazilian Sport horses aged between 2 and 6 years were evaluated. All animals presented OCD fragments in the middle crest of the tibia. Ten days after surgery, animals were randomly distributed into three groups and received intra-articular application of PRP (n = 6), HA (n = 6), or LR (control group, n = 6). Clinical, radiographic, ultrasound and synovial fluid evaluations were performed on the day of surgery and after 10, 30 and 60 days. An increase in the thickness of the joint capsule was observed 30 days after surgery in the three groups evaluated. In the control group, there was significant improvement in the flexion test 30 and 60 days after surgery, and in the PRP group, there was worsening of this parameter in the same evaluations. In the control group, there was a reduction in the degree of synovial effusion, and in the PRP and HA groups, there was increased effusion. There was a significant increase in the number of leukocytes in the HA group. Intra-articular use of PRP or HA ten days after arthroscopy did not promote positive effects on the recovery of horses with OCD.

Intravenous Regional Limb Perfusion in Standing and Recumbent Horses: A Comparative Radiographic Study.

Although pharmacokinetic studies of drugs administered by intravenous regional limb perfusion (IRLP) to treat equine orthopedic infections suggest efficient drug distribution in the limbs, it remains unclear whether drug perfusion is affected by the position of the horse during the procedure. This study compared the perfusion of a radiopaque contrast into tissues of the extremities of horses maintained in standing and recumbent positions during an IRLP. Radiopaque contrast was administered through IRLP into the cephalic vein of 10 healthy adult horses under general anesthesia and right lateral recumbency (RG) or under sedation and standing (SG). The same animals were used in both groups, respecting a two-week washout period. Sequential radiographic images were performed immediately at the beginning of contrast administration (T0) and after 10, 20, 30, 40, and 50 minutes. Tourniquets were removed after 30 minutes. The time required for the contrast to reach the hooves was compared between groups. Contrast reached the hooves faster in SG (114 ± 15 seconds) compared with RG (236 ± 29 seconds) (P < 0.5). SG showed more uniform perfusion of the limb vessels, whereas RG showed more deposition of the contrast in the lateral digital vein, with smaller amounts reaching the hooves. From T10 onward, soft tissue radiopacity increased, albeit more markedly in standing than in recumbent animals, remaining until T50. Contrast radiography evidenced that IRLP performed in standing position leads to a quicker and more uniform perfusion of the vasculature and a more noticeable diffusion to the tissues than in recumbent horses.

Behaviour of diferent types of chitosan membranes implanted in horses / Comportamento de diferentes tipos de membranas de quitosana implantadas em equinos

Chitosan has been successfully used as a biomaterial with several purposes in many species. In this study, chitosan membranes were produced with six different types of materials, and their behavior were evaluated upon implantation in the subcutaneous tissue of the flank of twelve healthy horses. We assessed chitosan membranes obtained from commercial chitosan, impregnated or not with silver nanoparticles, sterilized with ethylene oxide (CCEO, n=3; CCSNEO, n=3) or by ultraviolet radiation (CCUR, n=3; CCSNUR, n=3), and chitosan membranes obtained from squid gladius, sterilized with ethylene oxide (SCEO, n=6) or by ultraviolet radiation (SCUR, n=6). The same animals were randomly used in two experimental groups, with a minimum interval of 60 days between procedures, respecting the fact of only one flank side, left or right, be under evaluation by experimental period. After preparation of the membranes and implantation in the flank subcutaneous tissue of the horses, macroscopic and ultrasonographic evaluations of the implant regions were performed, as well as physical examination, blood count and fibrinogen measurement. No clinical or laboratory abnormalities were observed. All animals that received commercial chitosan membranes, regardless of the preparation technique, showed rejection to the biomaterials, considering that 100% of the surgical wounds presented dehiscence of suture and expulsion of the implants. The animals that received squid gladius chitosan membranes showed success in the treatment, with healing by primary intention of the surgical wound. We conclude that squid gladius chitosan membranes are biocompatible and biodegradable when implanted in the subcutaneous tissue of the flank of healthy horses.(AU)

A quitosana tem sido utilizada, com sucesso, como biomaterial para diversas espécies e finalidades. Neste estudo foi avaliada a confecção de membranas de quitosana, produzidas a partir de seis tipos de materiais diferentes e foi estudado seu comportamento quando implantadas no tecido subcutâneo do flanco de doze equinos sadios. Foram avaliadas membranas de quitosana obtidas de quitosana comercial, impregnadas ou não com nanopartículas de prata, esterilizadas com óxido de etileno (QCOE, n=3; QCNPOE, n=3) ou por radiação ultravioleta (QCRU, n=3; QCNPRU, n=3) e membranas de quitosana obtidas do gládio de lula, esterilizadas com óxido de etileno (GLOE, n=6) ou por radiação ultravioleta (GLRU, n=6). Os mesmos animais foram utilizados em dois grupos experimentais, de forma aleatória, com um intervalo mínimo de sessenta dias entre os procedimentos, respeitando-se o fato de apenas um lado do flanco, esquerdo ou direito, estar em avaliação por período experimental. Após preparo das membranas e implantação no tecido subcutâneo do flanco dos equinos, foram realizadas avaliações macroscópicas e ultrassonográficas das regiões de implante, além de exames físicos, hemogramas e fibrinogênio. Não foram observadas alterações clínicas e laboratoriais. Todos os animais que receberam membranas de quitosana comercial, independente da técnica de preparo, demonstraram rejeição dos biomateriais, uma vez que 100% das feridas cirúrgicas apresentaram deiscência da sutura e expulsão dos implantes. Os animais que receberam as membranas de quitosana de gladio de lula demonstraram sucesso no tratamento, com cicatrização das feridas cirúrgicas por primeira intenção. Conclui-se que membranas de quitosana de gládio de lula são biocompatíveis e biodegradáveis, quando implantadas no tecido subcutâneo do flanco de equinos sadios.(AU)